Oncolytics Biotech (ONC) News Today C$1.62 +0.02 (+1.25%) As of 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period TSE:ONC FY2025 EPS Forecast Increased by Leede FinancialJuly 13 at 2:47 AM | americanbankingnews.comTSE:ONC FY2025 EPS Forecast Lifted by Leede FinancialJuly 11 at 6:13 AM | marketbeat.comNext-Gen Cancer Treatments Gain Steam Amid Oncology Industry ShakeupsJuly 10, 2025 | baystreet.caOncolytics Biotech (TSE:ONC) Stock Price Up 24.1% - Here's What HappenedJuly 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading 24.1% Higher - Time to Buy?July 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Shares Up 24.1% - Still a Buy?July 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Shares Up 24.1% - Time to Buy?July 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Up 24.1% - Here's What HappenedJuly 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading 24.1% Higher - Here's WhyJuly 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Shares Up 24.1% - What's Next?July 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Up 24.1% - Should You Buy?July 9, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading 24.1% Higher - Here's What HappenedJuly 8, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Up 24.1% - Time to Buy?July 8, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Stock Price Up 24.1% - Should You Buy?July 8, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Up 24.1% - Still a Buy?July 8, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading Up 24.1% - Here's WhyJuly 8, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Shares Up 18.2% - Time to Buy?July 8, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Trading 16.8% Higher - Still a Buy?July 8, 2025 | marketbeat.comEquity Insider: Amid NCI Budget Fears, Emerging Oncology Stocks Gain AttentionJuly 8, 2025 | finanznachrichten.deInvestors Turn to Cancer Breakthroughs as Federal Funding Faces Deep CutsJuly 8, 2025 | baystreet.caOncolytics Biotech Inc.: Oncolytics Biotech Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development StrategyJune 30, 2025 | finanznachrichten.deWhy Early-Onset Cancers Are Alarming Researchers—and What It Means for InvestorsJune 30, 2025 | baystreet.caUSA News Group: The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?June 26, 2025 | finanznachrichten.deOncolytics Biotech (TSE:ONC) Stock Price Passes Below Two Hundred Day Moving Average - What's Next?June 25, 2025 | marketbeat.comNew Wave of Cancer Treatments Could Change the Game for Patients - and InvestorsJune 24, 2025 | baystreet.caOncolytic virus immunotherapy shows promise in HR+/HER2- breast cancer trialJune 24, 2025 | msn.comOncolytics Biotech (TSE:ONC) Shares Up 10.1% - Still a Buy?June 18, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Stock Passes Below 200-Day Moving Average - What's Next?June 17, 2025 | marketbeat.comBig Cuts to U.S. Cancer Research May Create Historic Opening for Biotech InvestorsJune 12, 2025 | baystreet.caEquity Insider: As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From IndustryJune 12, 2025 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech Names New CEO to Accelerate Momentum in Immunotherapy ProgramsJune 11, 2025 | finanznachrichten.deOncolytics Biotech stock takes off after naming new CEOJune 11, 2025 | msn.comOncolytics names Jared Kelly as CEOJune 11, 2025 | msn.comOncolytics Biotech (NASDAQ:ONCY) Stock, Short Interest ReportMay 29, 2025 | benzinga.comInvestor Attention Turns to Biotech as Traditional Cancer Research Models StrainMay 23, 2025 | baystreet.caOncolytics Biotech Q1 2025 Earnings PreviewMay 13, 2025 | msn.com1ONCY : A Look at Oncolytics Biotech's Upcoming Earnings ReportMay 13, 2025 | benzinga.comBuzz on the Bullboards: Energy, cannabis, and Biotech Shine on the TSXApril 17, 2025 | msn.comOncolytics Biotech (TSE:ONC) Sets New 1-Year Low - Here's What HappenedApril 11, 2025 | marketbeat.comSmall-cap cancer therapy innovator raises $20M in flexible fundingApril 11, 2025 | msn.comOncolytics Biotech (TSE:ONC) Hits New 12-Month Low - Here's WhyApril 5, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Hits New 1-Year Low - Time to Sell?March 29, 2025 | marketbeat.comOncolytics Biotech Inc.March 24, 2025 | wsj.comOncolytics Biotech (TSE:ONC) Reaches New 12-Month Low - Here's WhyMarch 19, 2025 | marketbeat.comHC Wainwright Has Optimistic View of TSE:ONC FY2026 EarningsMarch 14, 2025 | marketbeat.comLeede Financial Has Positive View of TSE:ONC FY2025 EarningsMarch 14, 2025 | marketbeat.comFY2028 Earnings Forecast for TSE:ONC Issued By HC WainwrightMarch 13, 2025 | marketbeat.comOncolytics Biotech (TSE:ONC) Hits New 1-Year Low - Here's WhyMarch 12, 2025 | marketbeat.comOncolytics Biotech: Continuing To Justify The NegativityMarch 10, 2025 | seekingalpha.comOncolytics price target lowered to C$5 from C$6 at RBC CapitalMarch 10, 2025 | markets.businessinsider.com Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.341.01▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼232▲ONC Articles Average Week Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fennec Pharmaceuticals News Theratechnologies News Covalon Technologies News Medicenna Therapeutics News Sernova News Aptose Biosciences News Helix BioPharma News Microbix Biosystems News Devonian Health Group News Hemostemix News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:ONC) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
